Citadel Advisors’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Buy |
290,951
+3,176
| +1% | +$155K | ﹤0.01% | 1162 |
|
|
2025
Q1 | $6.2M | Buy |
+287,775
| New | +$6.2M | ﹤0.01% | 1594 |
|
|
2024
Q2 | – | Sell |
-4,227
| Closed | -$77.8K | – | 5988 |
|
|
2024
Q1 | $77.8K | Buy |
+4,227
| New | +$77.8K | ﹤0.01% | 5177 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5957 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5920 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5863 |
|
|
2023
Q1 | – | Sell |
-15,081
| Closed | -$228K | – | 5970 |
|
|
2022
Q4 | $228K | Buy |
+15,081
| New | +$228K | ﹤0.01% | 4576 |
|
|
2022
Q3 | – | Sell |
-2,868
| Closed | -$28K | – | 5948 |
|
|
2022
Q2 | $28K | Buy |
+2,868
| New | +$28K | ﹤0.01% | 5647 |
|
|
2022
Q1 | – | Sell |
-6,309
| Closed | -$161K | – | 6409 |
|
|
2021
Q4 | $161K | Buy |
6,309
+5,027
| +392% | +$128K | ﹤0.01% | 5623 |
|
|
2021
Q3 | $57K | Buy |
1,282
+639
| +99% | +$28.4K | ﹤0.01% | 6075 |
|
|
2021
Q2 | $26K | Sell |
643
-424
| -40% | -$17.1K | ﹤0.01% | 6305 |
|
|
2021
Q1 | $57K | Buy |
+1,067
| New | +$57K | ﹤0.01% | 6062 |
|
|
2020
Q2 | – | Sell |
-522
| Closed | -$26K | – | 4686 |
|
|
2020
Q1 | $26K | Sell |
522
-448
| -46% | -$22.3K | ﹤0.01% | 4629 |
|
|
2019
Q4 | $74K | Buy |
+970
| New | +$74K | ﹤0.01% | 4339 |
|
|
2018
Q2 | – | Sell |
-732
| Closed | -$59K | – | 4201 |
|
|
2018
Q1 | $59K | Buy |
+732
| New | +$59K | ﹤0.01% | 3722 |
|
|
2017
Q3 | – | Sell |
-857
| Closed | -$129K | – | 3692 |
|
|
2017
Q2 | $129K | Buy |
+857
| New | +$129K | ﹤0.01% | 3261 |
|
|
2015
Q4 | – | Sell |
-1,220
| Closed | -$310K | – | 3928 |
|
|
2015
Q3 | $310K | Buy |
1,220
+60
| +5% | +$15.2K | ﹤0.01% | 2919 |
|
|
2015
Q2 | $325K | Buy |
+1,160
| New | +$325K | ﹤0.01% | 2795 |
|